tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sino Biopharmaceutical Declares Interim Dividend for 2025
PremiumCompany AnnouncementsSino Biopharmaceutical Declares Interim Dividend for 2025
21d ago
Sino Biopharmaceutical Reports Strong Interim Financial Results for 2025
Premium
Company Announcements
Sino Biopharmaceutical Reports Strong Interim Financial Results for 2025
22d ago
Sino Biopharmaceutical’s Innovative Cancer Drug TQB3142 Gains NMPA Approval for Clinical Trials
Premium
Company Announcements
Sino Biopharmaceutical’s Innovative Cancer Drug TQB3142 Gains NMPA Approval for Clinical Trials
28d ago
Sino Biopharmaceutical: Innovation-Driven Growth and Strong Financials Justify Buy Rating
PremiumRatingsSino Biopharmaceutical: Innovation-Driven Growth and Strong Financials Justify Buy Rating
1M ago
Sino Biopharmaceutical Schedules Board Meeting for Interim Results and Dividend Consideration
Premium
Company Announcements
Sino Biopharmaceutical Schedules Board Meeting for Interim Results and Dividend Consideration
1M ago
Sino Biopharmaceutical to Receive $300 Million Milestone Payment from Merck Collaboration
Premium
Company Announcements
Sino Biopharmaceutical to Receive $300 Million Milestone Payment from Merck Collaboration
1M ago
Sino Biopharmaceutical’s New Breast Cancer Treatment Gains Regulatory Acceptance
PremiumCompany AnnouncementsSino Biopharmaceutical’s New Breast Cancer Treatment Gains Regulatory Acceptance
2M ago
Sino Biopharmaceutical’s Anqixin® Approved for Marketing in China
Premium
Company Announcements
Sino Biopharmaceutical’s Anqixin® Approved for Marketing in China
2M ago
Sino Biopharmaceutical’s Anlotinib Combo Approved for Soft Tissue Sarcoma
Premium
Company Announcements
Sino Biopharmaceutical’s Anlotinib Combo Approved for Soft Tissue Sarcoma
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100